US11116663B2 - System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine - Google Patents

System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine Download PDF

Info

Publication number
US11116663B2
US11116663B2 US15/874,984 US201815874984A US11116663B2 US 11116663 B2 US11116663 B2 US 11116663B2 US 201815874984 A US201815874984 A US 201815874984A US 11116663 B2 US11116663 B2 US 11116663B2
Authority
US
United States
Prior art keywords
eye
alignment pattern
image
patient
light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US15/874,984
Other versions
US20190224043A1 (en
Inventor
Chris Sramek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iridex Corp
Original Assignee
Iridex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Assigned to TOPCON MEDICAL LASER SYSTEMS INC. reassignment TOPCON MEDICAL LASER SYSTEMS INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SRAMEK, Chris
Priority to US15/874,984 priority Critical patent/US11116663B2/en
Application filed by Iridex Corp filed Critical Iridex Corp
Priority to PCT/US2019/013421 priority patent/WO2019143544A1/en
Priority to JP2020530991A priority patent/JP2021511095A/en
Priority to EP19703467.1A priority patent/EP3740803A1/en
Publication of US20190224043A1 publication Critical patent/US20190224043A1/en
Assigned to IRIDEX CORPORATION reassignment IRIDEX CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TOPCON MEDICAL LASER SYSTEMS, INC.
Priority to US17/398,323 priority patent/US20220062036A1/en
Publication of US11116663B2 publication Critical patent/US11116663B2/en
Application granted granted Critical
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/13Ophthalmic microscopes
    • A61B3/135Slit-lamp microscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/0008Apparatus for testing the eyes; Instruments for examining the eyes provided with illuminating means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/0016Operational features thereof
    • A61B3/0025Operational features thereof characterised by electronic signal processing, e.g. eye models
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/13Ophthalmic microscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F9/00821Methods or devices for eye surgery using laser for coagulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B21/00Microscopes
    • G02B21/0004Microscopes specially adapted for specific applications
    • G02B21/0012Surgical microscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B2018/2015Miscellaneous features
    • A61B2018/2025Miscellaneous features with a pilot laser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/30Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure
    • A61B2090/306Devices for illuminating a surgical field, the devices having an interrelation with other surgical devices or with a surgical procedure using optical fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/008Methods or devices for eye surgery using laser
    • A61F2009/00861Methods or devices for eye surgery using laser adapted for treatment at a particular location
    • A61F2009/00863Retina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/063Radiation therapy using light comprising light transmitting means, e.g. optical fibres
    • A61N2005/067
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/067Radiation therapy using light using laser light

Definitions

  • the HUD system 113 is configured to receive the NIR image of the patient's eye 120 - 1 , superimpose the NIR image of the patient's eye 120 - 1 with direct image of patient's eye 120 - 1 and propagate the superimposed image of patient's eye 120 - 1 to user eye 130 - 1 .
  • the HUD display system 113 includes a light source, microdisplay, collimating optics, beam splitting optics for providing images to the observation paths (e.g., left and right paths), and beam-splitters in the observation path for directing visible light toward user 130 .
  • ophthalmic illumination and microscopic viewing system 100 is configured to project a circle around the beam to identify a “thermal damage zone” which is pre-computed using a computational model of laser-tissue heating or taken from clinical burn appearance database for different spot-size/pulse duration combinations (as described, e.g., in Daniel Palanker et al. “The Impact of Pulse Duration and Burn Grade on Size of Retinal Photocoagulation Lesion: Implications for Pattern Density” Retina 31.8 (2011): 1664-1669.)

Abstract

An ophthalmic illumination method and system with a head-up display imaging system is provided wherein a therapeutic light is generated by a first laser light source configured to generate therapeutic light and a near-infrared wavelength of an alignment pattern is generated by a second laser light source, where the therapeutic light is directed upon an eye to be examined or treated in accordance with the alignment pattern.

Description

TECHNICAL FIELD
The present invention is generally directed to ophthalmic photomedicine, and more specifically to systems and methods for generating laser treatment alignment patterns on a patient's eye.
BACKGROUND
Ophthalmic photomedicine (e.g., laser treatment or laser surgery) employing multiple-spot laser therapy is widely used today to treat various conditions of the eye such as diabetic retinopathy and age-related macular degeneration. Typically, multiple-spot laser therapy is performed by utilizing a slit-lamp-mounted laser treatment device or probes that are inserted into the patient's eye. In a slit-lamp-mounted laser treatment device, a slit lamp is arranged to allow illumination and microscopic viewing of a patient's eye. Slit lamps used in laser treatment or laser surgery typically include a high-brightness illuminator, which can be focused to shine a desired light pattern into a patient's eye, and a microscope mounted on a shared pivot point. The shared pivot point allows the viewing angle of the illuminator and microscope to be changed as often as desired without moving the field of illumination or visualization.
Laser treatment or laser surgery also requires the high-precision aiming of a treatment laser beam. A visible wavelength (e.g., 400-700 nm) aiming beam is often used to generate an alignment pattern (e.g., one or more spots, or a scanned image) that marks a target area on or within a patient's eye for guiding the treatment beam. The separate aiming beam and treatment beam are typically combined to propagate in a shared path, and both beams are projected onto the target area on or within the patient's eye. For example, a physician who is viewing the patient's eye can adjust the alignment pattern such that it overlays the desired target area. The physician may then activate the treatment beam, which is coincident with the alignment pattern. In this configuration, the alignment pattern is a so-called “real” image because the image is an actual pattern of light projected onto, and subsequently viewed from, the actual target area.
While the use of a visible wavelength aiming beam that is coincident with the treatment beam at the targeted eye structure works well in most situations, this technique does have certain shortcomings. For example, because the aiming beam is optically coupled to the patient's eye, the patient sees the alignment pattern before and/or during treatment, which can increase patient anxiety during the procedure. There may also be associated safety and/or discomfort issues because the aiming beam irradiance is generally higher in the patient's eye than in the physician's eye. Further, in some procedures it is preferable for the patient to not see the aiming beam at all. For example, in treatment near the eye's macula (i.e., the central region of highest visual acuity) the patient may inadvertently fix their gaze on the aiming beam resulting in unintended destruction of the patient's central vision.
Therefore, a need exists for an improved technique for generating alignment patterns in ophthalmic procedures.
BRIEF SUMMARY OF THE EMBODIMENTS
An ophthalmic photomedicine method and apparatus is provided that allows for the generation of an alignment pattern (i.e., treatment pattern) during procedures such as laser surgery or laser treatment where the alignment pattern is visible only to the individual (e.g., physician) administering the surgery or treatment but not the intended patient thereof.
In accordance with an embodiment, a first optical element is configured to direct light from a light source upon an organic object, illustratively, the eye of an individual (ie., patient) to be examined and treated. A micro-display projector forms a second optical element and is configured to generate a micro-display image including information associated with the eye to be examined. The micro-display projector may include one of a liquid crystal on silicon (LCoS), digital-micro-mirror (DMD) or micro-electro-mechanical systems (MEMS) micro-scanner, and one of a light-emitting diode (LED) or red-green-blue (RGB) laser light source. A third optical element is configured to (i) receive reflected light from the eye resulting from the light directed upon the eye; (ii) receive the micro-display image; and (iii) transmit at least a portion of the reflected light and at least a portion of the micro-display image.
Advantageously, in accordance with an embodiment, the system provides for a “real” alignment pattern where the aiming light is actually projected onto the target tissue (e.g., the patient's retina) and real-time image sensing is facilitated. In an embodiment, an alignment laser source generates a near-infra-red (NIR) alignment wavelength (i.e., an NIR aiming laser) for forming an alignment pattern for projection on a target tissue of the eye. As such, this eliminates the need for any superimposed target patterns on the patient's eye given the projection of the aiming light onto the target tissue.
In accordance with an embodiment, the third optical element may be further configured to transmit a stereoscopic image of the portion of the reflected light and the portion of the micro-display image. The third optical element may be a beam-splitter.
These and other advantages of the invention will be apparent to those of ordinary skill in the art by reference to the following detailed description and the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 shows an ophthalmic illumination and microscopic viewing system in accordance with an embodiment;
FIG. 2 shows a flowchart of an ophthalmic illumination method in accordance with an embodiment;
FIGS. 3A and 3B show images of an aiming beam projected by a heads-up display system in accordance with an embodiment; and
FIG. 4 shows a high-level block diagram of an exemplary computer that may be used for the various embodiments herein.
DETAILED DESCRIPTION
FIG. 1 shows an ophthalmic illumination and microscopic viewing system 100 in accordance with an embodiment. Ophthalmic illumination and microscopic viewing system 100 comprises a laser generation system 101, laser delivery system 110, observation optical system 111, illumination optical system 108, Near-Infra-Red (NIR) imaging system 112, and a Heads-up (or Head-up) display (HUD) system 113.
Laser generation system 101 includes a treatment laser source 102 and an alignment laser source 103 and may be illustratively operated by user 130 (e.g., a treating physician or other practitioner) who is examining patient 120. Laser generation system 101 is communicably coupled with a controller 107 which is communicably coupled with a graphical user interface 116. Treatment laser source 102 generates therapeutic light (i.e., “treatment laser”) 104 to be used for treatment of an organic object, illustratively, patient's eye 120-1 or patient's eye 120-2. Alignment laser source 103 generates a near-infra-red (NIR) alignment wavelength (i.e., “NIR aiming laser”) 105 for projection on a target tissue of the patient's eye 120-1 in a form of an alignment pattern. Laser generation system 101 is configured to couple treatment laser 104 generated by treatment laser source 102 with NIR aiming laser 105 generated by alignment laser source 103 into one or more optical fibers 106 to propagate coupled treatment laser 104 and NIR aiming laser 105 to laser delivery system 110. It will be understood that any reference herein to patient's eye 120-1 will apply equally to patient's eye 120-2 and for ease of explanation herein below, reference to patient's eye 120-1 will be utilized. Similarly, it will be understood that any reference herein to user's eye 130-1 will apply equally to patient's eye 130-2 and for ease of explanation herein below, reference to user's eye 130-1 will be utilized.
Laser delivery system 110 is a component of an observation optical system 111 configured to propagate coupled treatment laser 104 and NIR aiming laser 105 through the observation optical system 111 to patient's eye 120-1. Observation optical system 111 is configured to provide a direct magnified view of patient's eye 120-1 to user's eye 130-1 and/or user's eye 130-2. Illumination optical system 108 is configured to illuminate the patient's eye 120-1 with visible light 124 and near infrared light 109.
In the embodiment, NIR imaging system 112 includes a charge-coupled device (CCD) 114. The NIR imaging system 112 is positioned to capture and direct an NIR wavelength 121 scattered from the eye tissue of the patient's eye 120-1 to CCD 114. In an embodiment, CCD 114 includes a notch filter configured to attenuate wavelengths other than the NIR aiming laser 105. The NIR imaging system 112 may include a beam-splitter configured to perform the operations of directing NIR wavelength 121 scattered from the eye tissue of patient's eye 120-1 to CCD 114. An exemplary beam-splitter may include a glass or plastic cube, a half-silvered mirror (e.g., a sheet of glass or plastic with a thin coating of metal or dichroic optical coating) or a dichroic mirrored prism. In the embodiment, instead of a notch filter, CCD 114 may include a long-pass NIR filter to overlay NIR image of patient's eye 120-1 with a direct view.
HUD system 113 is configured to receive the NIR image of the patient's eye 120-1, superimpose the NIR image of the patient's eye 120-1 with direct image of patient's eye 120-1 and propagate the superimposed image of patient's eye 120-1 to user eye 130-1. In an embodiment, the HUD display system 113 includes a light source, microdisplay, collimating optics, beam splitting optics for providing images to the observation paths (e.g., left and right paths), and beam-splitters in the observation path for directing visible light toward user 130.
In the embodiment, optical fiber 108, in which the treatment laser 104 and NIR aiming laser 105 are co-aligned and coupled, is routed through laser delivery system 110 to observation optical system 111 (e.g., ophthalmoscope). Further, controller 107 is configured to generate and transmit user commands to laser generation system 101 based on user input received via GUI 116. Controller 107 may also be configured to receive inputs from one or more external sources (e.g. a camera flash trigger or a computer processing real-time slit-lamp video). It is to be understood that GUI 116 may be a touch-screen display, LCD with a mouse/trackpad interface, and the like.
In the embodiment, ophthalmic illumination and microscopic viewing system 100 is configured to employ the same fiber(s) for treatment laser 104 and NIR aiming laser 105. In an alternative embodiment, ophthalmic illumination and microscopic viewing system 100 may be configured to employ separate (i.e., different) fibers dedicated for treatment laser 104 and NIR aiming laser 105 within laser delivery system 110.
In accordance with an embodiment, the observation optical system 111 is configured to propagate a composite image of the patient's eye 120-1 with an overlaid image of an alignment pattern where five to fifteen percent (5-15%) of light is associated with the overlaid image, resulting in a high-quality overlaid image of the patient's eye 120-1. For example, about ninety percent (90%) of the overlaid image passes through the beam splitter. The overlaid image is practically invisible when only about ten percent (10%) of the overlaid image is transmitted. One skilled in the art will appreciate that other ratios of projected light allowed to be passed through are possible. Further, in an embodiment, the observation optical system 111 is configured to preferably allow between about ninety to ninety-nine (90-99%) of the reflected light 124 to pass through from patient's eye 120-1 toward user 130 (and user's eye 130-1). For example, about one percent (1%) of the reflected light 124 is lost when the observation optical system 111 is configured to allow ninety-nine (99%) of the reflected light 124 from patient's eye 120-1 to pass through toward user 130 (and user's eye 130-1). Again, one skilled in the art will appreciate that other ratios of reflected light 124 allowed to pass through or be reflected are possible.
When the ophthalmic illumination and microscopic viewing system 100 is using a “real” alignment pattern, the NIR aiming laser 105 is actually projected onto the target tissue. Actual projection of NIR aiming laser 105 onto the target tissue of patient's eye 120-1 has a distinct advantage over the “virtual” approach described above in that the observed (via HUD system 113) aiming beam defocuses realistically, since what is being imaged on retina of the patient's eye 120-1 is an actual defocused NIR aiming laser 105 rather than a virtual projection. That is, user 130 directly observes (illustratively, user's eye 130-1) patient's eye 120-1 through the observation optical system 111, and a view of the retina of patient's eye 120-1 in NIR light (showing only the aiming laser 105) is superimposed on the direct view with the HUD system 113.
A light scattered from target tissue of the patient's eye 120-1 is collected within the observation optical system 111. Visible light 124 is directly viewed by user eye 130-1 through an eyepiece of the observation optical system 111. The NIR aiming laser 105 is reflected as reflection wavelength 121 into the NIR imaging system 112. The NIR imaging system 112, using, for example, a notch filter, attenuates all wavelengths outside the narrow band corresponding to the wavelength of NIR aiming laser 105. Upon receiving reflection wavelength 121 of NIR aiming laser 105, the NIR imaging system 112 generates video image frames of NIR beam on eye tissue of the patient's eye 120-1 and transmits the generated video image frames to the HUD display system 113.
It is to be understood that a composite image of patient's eye 120-1 with an overlaid image of the alignment pattern may also include concurrent information, including any type of image or data that may be associated with patient's eye 120-1. For example, concurrent information may include patient information, the current time and date, or other information that may be of use in a clinical environment. In another example, concurrent information may include measurement information, such as a measurement axis, distance, area, scale or grid. Measurement information also may include a current illumination area diameter, current slit width, inter-slit spacing, current filter choice, micrometer scale labeling, or circle/ellipse radii, ratios and areas.
When illumination system 108 is used in conjunction with therapy systems including laser systems and other equipment, concurrent information may include one of a treatment parameter or a preoperative image, treatment plan, an aiming beam pattern indicator or a treatment beam target indicator. In yet other example, concurrent information may include information regarding treatment laser parameters, such as, e.g., power, spot-size and spacing.
In an alternative implementation of ophthalmic illumination and microscopic viewing system 100, alignment laser source 103 generating NIR aiming laser 105 may be located within laser delivery system 110. In this case, laser delivery system 110 is configured to use beam-shaping/collimation optics to couple treatment laser 104 with NIR aiming laser 105 into one or more optical fibers within laser delivery system 110. The one or more optical fibers direct coupled treatment laser 104 and NIR aiming laser 105 to patient's eye 120-1.
It is to be understood that laser generation system 101, NIR imaging system 112 and HUD system 113 can be implemented in such a way that there is no data connection between controller 107, NIR imaging system 112 and HUD system 113. In this case, NIR imaging system 112 and HUD system 113 detect NIR light in a narrow band corresponding to the NIR aiming laser 105 and superimposing NIR aiming laser 105 on the direct view of patient's eye 120-1, without data exchange with the controller 107. It is also to be understood that the color of the aiming beam projected by HUD system 113 to the user 130 can be arbitrarily set, as opposed to using an often-used long red wavelengths, to provide maximum user visibility of an alignment beam.
In an alternative embodiment of ophthalmic illumination and microscopic viewing system 100, NIR aiming laser 105 may be generated by treatment laser source 103 using, illustratively, a residual pump prior to frequency doubling. In a further embodiment of ophthalmic illumination and microscopic viewing system 100, NIR aiming laser 105 is configured to have a shared function with a NIR imaging system 112 (e.g., an optical coherence tomography (OCT) or scanning laser opthalmoscope (SLO) imaging system). In a further embodiment, ophthalmic illumination and microscopic viewing system 100 may be configured to include separate NIR channel (e.g., free space or fiber-coupled) with polarizer, cross-polarized before CCD 114 to reduce reflections. In an alternative embodiment, NIR imaging system 112 and HUD system 113 may be configured to share a common beam-splitter having an internal beam-splitter coating to reflect the NIR signal and transmit the visible signal at a 90:10 split-ratio.
FIG. 2 is a flowchart of illustrative operations for an ophthalmic illumination method in accordance with an embodiment. For ease of illustration, FIG. 2 is discussed below with reference also to FIG. 1. At step 210, a parameter for generating a composite image of patient's eye 120-1 is received. Referring to FIG. 1, controller 107 may be illustratively configured to receive, via GUI 116, a parameter for generating the composite image of patient's eye 120-1, wherein the parameter is related to concurrent information relating to patient data, a treatment parameter, a preoperative image, or a treatment plan. Receipt of the parameter by processor 107 initiates an alignment phase of laser treatment. During the alignment phase, visible or invisible (NIR) aiming laser 105 is selected. In an embodiment, the selection of visible or invisible (NIR) aiming laser 105 is implemented as a so-called “aiming visibility” slider bar in GUI where the higher visibility indicator corresponds to visible wavelength and where the lower visibility indicator corresponds to NIR wavelength.
At step 220, a command based on the received parameter is generated for the laser generation system 101 and for the illumination optical system 108. Referring back to FIG. 1, the controller 107 illustratively transmits a command to the illumination optical system 108 to generate a light beam 109 to be directed toward the patient's eye 120-1. Light beam 109 strikes patient's eye 120-1 and is reflected, generating reflected light 124. Reflected light 124 is propagated through the observation optical system 111 toward the user 130, allowing the user to view structures within patient's eye 120-1.
Concurrently, the controller 107 transmits a command to laser generation system 101 for the aiming laser source 103 to generate an aiming laser 105 based on the parameter. The generated NIR aiming laser 105 is directed to patient's eye 120-1 via laser delivery system 110 and projected onto patient's eye 120-1 in the form of an alignment pattern in accordance with the command. Laser delivery system 110 scans at least the X/Y pattern and modifies beam magnification to create a spot size/pattern on eye tissue of patient's eye 120-1 (co-aligned with illumination optical system 118) according to user input to controller 107 via GUI 116.
At step 230, a composite image of patient's eye 120-1 with an overlaid image of the alignment pattern using reflection wavelength 121 of NIR aiming laser 105 is generated in the HUD system 113. To generate a composite image of patient's eye 120-1, the ophthalmic illumination and microscopic viewing system 100 is configured to use virtual spot-size selection for an alignment pattern or real alignment pattern for the NIR aiming laser 105. At step 240, the composite image 123 of patient's eye 120-1 is directed as video image frames for observation to the user 130 through the eyepiece of the observation optical system 111. Accordingly, user 130 receives a composite image that includes an image of patient's eye 120-1 and the overlaid image of the alignment pattern propagated by the reflection wavelength 121 of NIR aiming laser 105. In an embodiment, the composite image of patient's eye 120-1 includes concurrent information relating to patient data, a treatment parameter, a preoperative image, or a treatment plan.
In an embodiment, the observation optical system 111 is configured to transmit approximately ten percent (10%) of reflected light 124 and allow approximately ninety percent (90%) of the reflected light to pass through (i.e., to be lost). The observation optical system 111 also may be configured to allow approximately ninety-nine (99%) of reflected light 124 to pass through toward user 130 and allow approximately one percent (1%) of the reflected light 124 to be reflected and lost. As such, ophthalmic illumination and microscopic viewing system 100 with a micro-display overlaid image source as disclosed herein may serve as a replacement for a slit-lamp illuminator with a traditional overlaid image source.
In the case of virtual spot-size selection, single, the laser delivery system 110 causes minimally sized NIR spot-size to be aimed on retina of the patient's eye 120-1 (using, for example, single mode fiber or directly imaged laser diode emitter). Reflected NIR aiming laser is captured by CCD 114 which calculates a treatment spot-size parameter which is the point-spread function of laser delivery system 110 and observation optical system 112. A calculated treatment spot-size parameter is then communicated from CCD 114 to HUD system 113 via communication link 122. HUD system 113 then performs (illustratively by processor 115) numerical two-dimensional convolution, in a well-known fashion, between CCD video image frames and kernel corresponding to true treatment beam spot-size and HUD system 113 displays the convolved video image frames. The convolved video images are the images of “virtual” correctly-sized and appropriately focused/defocused aiming laser 105.
For example, FIGS. 3A and 3B show a series of convolved video image frames. In particular, FIG. 3A shows convolved image 300 (having individual convolved image frames 300-1, 300-2, 300-3, 300-4, 300-5, 300-6, 300-7, 300-8, 300-9, 300-10, 300-11, 300-12, 300-13, 300-14, and 300-15) with the aiming laser 105 having a convolution kernel modified to have a circular top-hat beam shape. Further, FIG. 3B shows convolved image 310 (having individual convolved image frames 310-1, 310-2, 310-3, 310-4, 310-5, 310-6, 310-7, 310-8, 310-9, 310-10, 310-11, 310-12, 310-13, 310-14, and 310-15) with the aiming laser 105 having a convolution kernel modified to have an annular beam shape. As shown in FIGS. 3A and 3B, respectively, the delivery of the above-described ophthalmic illumination method and system results in correctly-sized aiming beam with appropriate focusing and defocusing characteristics. In this way, in accordance with the embodiments, an ophthalmic procedure (e.g., laser treatment and/or laser surgery) proceeds such that the responsible health care provider (e.g., physician) has a view of the alignment pattern(s) but not the patient undergoing the procedure. It is to be understood that a convolutional kernel may be modified to change the beam shape of the aiming laser 105 to be of any arbitrary geometric shape. It is also to be understood that convolution kernel can be modified to compensate for imperfections in the true NIR beam shape (e.g. stripe from laser diode source).
Alternatively, ophthalmic illumination and microscopic viewing system 100 may utilize an informationally-enhanced aiming beam based on real-time processing of video image frames. In order to utilize the informationally-enhanced aiming beam, ophthalmic illumination and microscopic viewing system 100 is configured to detect NIR aiming laser 105 as being in or near focus (e.g. convolution with nominal spot pattern or maximum contrast detection), and indicate with, for example, a color change of the HUD-projected aiming beam spot. Alternatively (or concurrently), when it is determined that NIR aiming laser 105 is in focus, ophthalmic illumination and microscopic viewing system 100 is configured to project a circle around the beam to identify a “thermal damage zone” which is pre-computed using a computational model of laser-tissue heating or taken from clinical burn appearance database for different spot-size/pulse duration combinations (as described, e.g., in Daniel Palanker et al. “The Impact of Pulse Duration and Burn Grade on Size of Retinal Photocoagulation Lesion: Implications for Pattern Density” Retina 31.8 (2011): 1664-1669.)
As detailed above, the various embodiments herein can be embodied in the form of methods and apparatuses for practicing those methods. The disclosed methods may be performed by a combination of hardware, software, firmware, middleware, and computer-readable medium (collectively “computer”) installed in and/or communicatively connected to a user device. FIG. 4 is a high-level block diagram of an exemplary computer 400 that may be used for implementing a method for ophthalmic illumination in accordance with the various embodiments herein. Computer 400 comprises a processor 410 operatively coupled to a data storage device 420 and a memory 430. Processor 410 controls the overall operation of computer 400 by executing computer program instructions that define such operations. Communications bus 460 facilitates the coupling and communication between the various components of computer 400.
The computer program instructions may be stored in data storage device 420, or a non-transitory computer readable medium, and loaded into memory 430 when execution of the computer program instructions is desired. Thus, the steps of the disclosed method (see, e.g., FIG. 2) and the associated discussion herein above can be defined by the computer program instructions stored in memory 430 and/or data storage device 420 and controlled by processor 410 executing the computer program instructions. For example, the computer program instructions can be implemented as computer executable code programmed by one skilled in the art to perform the illustrative operations defined by the disclosed method. Accordingly, by executing the computer program instructions, processor 410 executes an algorithm defined by the disclosed method. Computer 400 also includes one or more communication interfaces 450 for communicating with other devices via a network (e.g., a wireless communications network) or communications protocol (e.g., Bluetooth®). For example, such communication interfaces may be a receiver, transceiver or modem for exchanging wired or wireless communications in any number of well-known fashions. Computer 400 also includes one or more input/output devices 440 that enable user interaction with computer 400 (e.g., camera, display, keyboard, mouse, speakers, microphone, buttons, etc.).
Processor 410 may include both general and special purpose microprocessors, and may be the sole processor or one of multiple processors of computer 400. Processor 410 may comprise one or more central processing units (CPUs), for example. Processor 410, data storage device 420, and/or memory 430 may include, be supplemented by, or incorporated in, one or more application-specific integrated circuits (ASICs) and/or one or more field programmable gate arrays (FPGAs).
Data storage device 420 and memory 430 each comprise a tangible non-transitory computer readable storage medium. Data storage device 420, and memory 430, may each include high-speed random access memory, such as dynamic random access memory (DRAM), static random access memory (SRAM), double data rate synchronous dynamic random access memory (DDR RAM), or other random access solid state memory devices, and may include non-volatile memory, such as one or more magnetic disk storage devices such as internal hard disks and removable disks, magneto-optical disk storage devices, optical disk storage devices, flash memory devices, semiconductor memory devices, such as erasable programmable read-only memory (EPROM), electrically erasable programmable read-only memory (EEPROM), compact disc read-only memory (CD-ROM), digital versatile disc read-only memory (DVD-ROM) disks, or other non-volatile solid state storage devices.
Input/output devices 440 may include peripherals, such as a camera, printer, scanner, display screen, etc. For example, input/output devices 440 may include a display device such as a cathode ray tube (CRT), plasma or liquid crystal display (LCD) monitor for displaying information to the user, a keyboard, and a pointing device such as a mouse or a trackball by which the user can provide input to computer 400.
It should be noted that for clarity of explanation, the illustrative embodiments described herein may be presented as comprising individual functional blocks or combinations of functional blocks. The functions these blocks represent may be provided through the use of either dedicated or shared hardware, including, but not limited to, hardware capable of executing software. Illustrative embodiments may comprise digital signal processor (“DSP”) hardware and/or software performing the operation described herein. Thus, for example, it will be appreciated by those skilled in the art that the block diagrams herein represent conceptual views of illustrative functions, operations and/or circuitry of the principles described in the various embodiments herein. Similarly, it will be appreciated that any flowcharts, flow diagrams, state transition diagrams, pseudo code, program code and the like represent various processes which may be substantially represented in computer readable medium and so executed by a computer, machine or processor, whether or not such computer, machine or processor is explicitly shown. One skilled in the art will recognize that an implementation of an actual computer or computer system may have other structures and may contain other components as well, and that a high level representation of some of the components of such a computer is for illustrative purposes.
Systems, apparatus, and methods described herein may be implemented using digital circuitry, or using one or more computers using well-known computer processors, memory units, storage devices, computer software, and other components. Typically, a computer includes a processor for executing instructions and one or more memories for storing instructions and data. A computer may also include, or be coupled to, one or more mass storage devices, such as one or more magnetic disks, internal hard disks and removable disks, magneto-optical disks, optical disks, etc.
Systems, apparatus, and methods described herein may be implemented using computers operating in a client-server relationship. Typically, in such a system, the client computers are located remotely from the server computer and interact via a network. The client-server relationship may be defined and controlled by computer programs running on the respective client and server computers.
Systems, apparatus, and methods described herein may be used within a network-based cloud computing system. In such a network-based cloud computing system, a server or another processor that is connected to a network communicates with one or more client computers via a network. A client computer may communicate with the server via a network browser application residing and operating on the client computer, for example. A client computer may store data on the server and access the data via the network. A client computer may transmit requests for data, or requests for online services, to the server via the network. The server may perform requested services and provide data to the client computer(s). The server may also transmit data adapted to cause a client computer to perform a specified function, e.g., to perform a calculation, to display specified data on a screen, etc. For example, the server may transmit a request adapted to cause a client computer to perform one or more of the method steps described herein, including one or more of the steps of FIG. 2. Certain steps of the methods described herein, including one or more of the steps of FIG. 2, may be performed by a server or by another processor in a network-based cloud-computing system, and/or performed by a client computer in a network-based cloud computing system. The steps of the methods described herein may be performed by a server and/or by a client computer in a network-based cloud computing system, in any combination.
Systems, apparatus, and methods described herein may be implemented using a computer program product tangibly embodied in an information carrier, e.g., in a non-transitory machine-readable storage device, for execution by a programmable processor; and the method steps described herein, including one or more of the steps of FIG. 2, may be implemented using one or more computer programs that are executable by such a processor. A computer program is a set of computer program instructions that can be used, directly or indirectly, in a computer to perform a certain activity or bring about a certain result. A computer program can be written in any form of programming language, including compiled or interpreted languages, and it can be deployed in any form, including as a stand-alone program or as a module, component, subroutine, or other unit suitable for use in a computing environment.
The foregoing Detailed Description is to be understood as being in every respect illustrative and exemplary, but not restrictive, and the scope of the invention disclosed herein is not to be determined from the Detailed Description, but rather from the claims as interpreted according to the full breadth permitted by the patent laws. It is to be understood that the embodiments shown and described herein are only illustrative of the principles of the present invention and that various modifications may be implemented by those skilled in the art without departing from the scope and spirit of the invention. Those skilled in the art could implement various other feature combinations without departing from the scope and spirit of the invention.

Claims (20)

What is claimed is:
1. An ophthalmic illumination and microscopic viewing system, comprising:
a first laser light source configured to generate therapeutic light;
at least one second laser light source configured to generate an alignment pattern formed from a patient-invisible wavelength;
a processor configured to generate an image based on reflected light from an organic object resulting from the alignment pattern directed thereupon; and
an optical system configured to receive the image generated by the processor and reflected light from the organic object resulting from light directed thereupon, and transmit the received image and the received reflected light while superimposing the received image with the received reflected light,
wherein the therapeutic light is directed upon the organic object in accordance with the alignment pattern.
2. The ophthalmic illumination and microscopic viewing system of claim 1, wherein the organic object is an eye under examination.
3. The ophthalmic illumination and microscopic viewing system of claim 2, wherein the therapeutic light and the alignment pattern are co-aligned for direction upon the eye.
4. The ophthalmic illumination and microscopic viewing system of claim 2, wherein the alignment pattern is made visible to a user of the ophthalmic illumination and microscopic viewing system examining the eye via a heads up display system.
5. The ophthalmic illumination and microscopic viewing system of claim 2, wherein the therapeutic light and the alignment pattern are directed upon the eye in accordance with an X-Y pattern scan.
6. The ophthalmic illumination and microscopic viewing system of claim 2, wherein the processor is configured to generate the image as a composite image including information associated with the eye.
7. The ophthalmic illumination and microscopic viewing system of claim 1, further comprising:
a controller to receive a parameter for selecting a particular wavelength value for the patient-invisible wavelength, and transmit a command based on the received parameter to the at least one second laser light source.
8. The ophthalmic illumination and microscopic viewing system of claim 7, wherein the particular wavelength is the patient-invisible wavelength and the alignment pattern is formed using the patient-invisible wavelength.
9. The ophthalmic illumination and microscopic viewing system of claim 2, wherein, the optical system to receive the reflected light from the eye resulting from the alignment pattern being directed thereupon, and transmit at least a portion of the reflected light from the eye resulting from the alignment pattern to a charge-coupled device.
10. The ophthalmic illumination and microscopic viewing system of claim 9, wherein the charge-coupled device includes a notch filter corresponding to the patient-invisible wavelength of the alignment pattern.
11. An ophthalmic illumination method, comprising:
generating a therapeutic light from a first laser light source;
generating an alignment pattern formed by a patient-invisible wavelength from a second laser light source;
generating an image based on reflected light from an organic object resulting from the alignment pattern directed thereupon;
receiving the generated image and reflected light from the organic object resulting from light directed thereupon;
transmitting the received image and the received reflected light while superimposing the received image with the received reflected light; and
directing the therapeutic light upon the organic object in accordance with the alignment pattern.
12. The method of claim 11, wherein the organic object is an eye.
13. The method of claim 12, wherein the generating the image generates a composite image of the eye as the image, the composite image including information associated with the eye.
14. The method of claim 13, further comprising:
routing the therapeutic light and the alignment pattern into one or more optical fibers.
15. The method of claim 13, further comprising:
receiving a parameter for selecting a particular wavelength associated with the alignment pattern; and
forming the alignment pattern using the particular wavelength.
16. The method of claim 12, wherein the alignment pattern is made visible to a user examining the eye via a heads up display system.
17. The method of claim 12, wherein the therapeutic light and the alignment pattern are co-aligned for direction upon the eye.
18. A non-transitory computer-readable medium storing computer program instructions for ophthalmic illumination, the computer program instructions, when executed on a processor, cause the processor to perform operations comprising:
generating a therapeutic light from a first laser light source;
generating an alignment pattern formed by a patient-invisible wavelength from a second laser light source;
generating an image based on reflected light from an eye resulting from the alignment pattern directed thereupon;
receiving the generated image and reflected light from the eye resulting from light directed thereupon;
transmitting the received image and the received reflected light while superimposing the received image with the received reflected light; and
directing the therapeutic light upon the eye in accordance with the alignment pattern.
19. The non-transitory computer-readable medium of claim 18 wherein the operations further comprising:
directing the therapeutic light and the alignment pattern upon the eye in accordance with an X-Y pattern scan and wherein the alignment pattern is made visible to a user examining the eye via a heads up display system.
20. The non-transitory computer-readable medium of claim 19, wherein generating the image generates a composite image as the image, the composite image including information associated with the eye.
US15/874,984 2018-01-19 2018-01-19 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine Active 2038-04-28 US11116663B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US15/874,984 US11116663B2 (en) 2018-01-19 2018-01-19 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine
PCT/US2019/013421 WO2019143544A1 (en) 2018-01-19 2019-01-14 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine
JP2020530991A JP2021511095A (en) 2018-01-19 2019-01-14 Systems and Methods for Invisible Laser Treatment Alignment Patterns for Patients in Ophthalmic Optical Medicine
EP19703467.1A EP3740803A1 (en) 2018-01-19 2019-01-14 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine
US17/398,323 US20220062036A1 (en) 2018-01-19 2021-08-10 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/874,984 US11116663B2 (en) 2018-01-19 2018-01-19 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/398,323 Continuation US20220062036A1 (en) 2018-01-19 2021-08-10 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine

Publications (2)

Publication Number Publication Date
US20190224043A1 US20190224043A1 (en) 2019-07-25
US11116663B2 true US11116663B2 (en) 2021-09-14

Family

ID=65279679

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/874,984 Active 2038-04-28 US11116663B2 (en) 2018-01-19 2018-01-19 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine
US17/398,323 Pending US20220062036A1 (en) 2018-01-19 2021-08-10 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine

Family Applications After (1)

Application Number Title Priority Date Filing Date
US17/398,323 Pending US20220062036A1 (en) 2018-01-19 2021-08-10 System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine

Country Status (4)

Country Link
US (2) US11116663B2 (en)
EP (1) EP3740803A1 (en)
JP (1) JP2021511095A (en)
WO (1) WO2019143544A1 (en)

Citations (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1015314B (en) 1955-08-16 1957-09-05 August Schwarz Fa Locking arrangement for pneumatic copiers
US4196980A (en) 1974-06-20 1980-04-08 Propper Manufacturing Co., Inc. Opthalmoscope examination pattern having light transmissive fixation point
WO1986000512A1 (en) 1984-07-14 1986-01-30 G. Rodenstock Instrumente Gmbh Eye testing apparatus for examining the bottom of the eye
EP0221649A2 (en) 1985-09-09 1987-05-13 Ocular Instruments, Inc. Slit lamp attachment
JPS62109542A (en) 1985-09-09 1987-05-20 オキユラ− インストルメンツ,インコ−ポレイテツド Attachment for slit lamp
WO1987005204A1 (en) 1986-03-08 1987-09-11 G. Rodenstock Instrumente Gmbh Slit lamp for the laser treatment of the eye
JPS6450009A (en) 1987-08-21 1989-02-27 Minolta Camera Kk Light beam scanner
US4917486A (en) 1987-05-20 1990-04-17 Scientific Generics Ltd. Photocoagulation apparatus
US4995716A (en) 1989-03-09 1991-02-26 Par Technology Corporation Method and apparatus for obtaining the topography of an object
US5299310A (en) 1992-01-15 1994-03-29 Ricoh Company, Ltd. Flexible frame buffer for raster output devices
JPH08117193A (en) 1994-10-20 1996-05-14 Topcon Corp Fundus camera
US5912720A (en) 1997-02-13 1999-06-15 The Trustees Of The University Of Pennsylvania Technique for creating an ophthalmic augmented reality environment
US5943118A (en) 1998-03-19 1999-08-24 Carl Zeiss Jena Gmbh Arrangement and method for illumination in a stereoscopic ophthalmic microscope
WO2000027273A1 (en) 1998-11-06 2000-05-18 Q-Vis Limited Eye tracker for refractive surgery
JP2000262476A (en) 1999-03-15 2000-09-26 Carl Zeiss Jena Gmbh Lighting system in optometric three-dimensional microscope and method therefor
US6394601B1 (en) 2000-07-17 2002-05-28 David S. Bettinger Spectacle-mounted micro display ocular
US20030071970A1 (en) 2001-10-17 2003-04-17 Carl Zeiss Meditec Ag Ophthalmologic examination instrument
EP1400829A1 (en) 2002-09-17 2004-03-24 Leica Microsystems (Schweiz) AG Microscope for ophthalmologic surgery with object illumination
US20050107708A1 (en) 2002-01-10 2005-05-19 Walter Wrobel Arrangement and method for illuminating the lens of the human eye
US20050277913A1 (en) 2004-06-09 2005-12-15 Mccary Brian D Heads-up display for displaying surgical parameters in a surgical microscope
US20050288564A1 (en) * 2004-06-18 2005-12-29 Iuliano Michael J Method and apparatus for performing in-vivo blood analysis using raman spectrum
US20070126985A1 (en) * 2005-10-28 2007-06-07 Wiltberger Michael W Photomedical treatment system and method with a virtual aiming device
US20080015553A1 (en) * 2006-07-12 2008-01-17 Jaime Zacharias Steering laser treatment system and method of use
US20080018987A1 (en) 2006-07-20 2008-01-24 Microvision, Inc. Compact multicolor light beam source
EP2012696A2 (en) 2006-04-28 2009-01-14 Optimedica Corporation Dynamic optical surgical system utilizing a fixed relationship between target tissue visualization and beam delivery
US20090093798A1 (en) 2007-10-05 2009-04-09 Steven Thomas Charles Semi-automated ophthalmic photocoagulation method and apparatus
US20090153796A1 (en) 2005-09-02 2009-06-18 Arthur Rabner Multi-functional optometric-ophthalmic system for testing diagnosing, or treating, vision or eyes of a subject, and methodologies thereof
WO2009145738A1 (en) 2008-05-30 2009-12-03 Optotek D.O.O. Slit lamp with an optoelectronic slit
US7766481B2 (en) 2004-04-24 2010-08-03 Carl Zeiss Meditec Gmbh Device for illuminating organic objects
US20100202036A1 (en) 2007-11-29 2010-08-12 Oasis Advanced Engineering, Inc. Multi-purpose periscope with display and overlay capabilities
US20100271594A1 (en) 2007-04-13 2010-10-28 Carl Zeiss Meditec Ag Device and Method for Axial Length Measurement Having Expanded Measuring Function in the Anterior Eye Segment
US20110052042A1 (en) 2009-08-26 2011-03-03 Ben Tzvi Jacob Projecting location based elements over a heads up display
CN202044247U (en) 2011-05-03 2011-11-23 上海美沃精密仪器有限公司 Micro-display slit device
WO2012060724A1 (en) 2010-11-05 2012-05-10 Anthony Philip Wells Eye examination system
US20120165906A1 (en) 2006-07-07 2012-06-28 Od-Os Gmbh Ophthalmoscope including virtual position patterning for therapy beam application
CN102768403A (en) 2011-05-03 2012-11-07 上海美沃精密仪器有限公司 Micro-display slit system and micro-display slit method
US20130128228A1 (en) 2006-01-20 2013-05-23 Clarity Medical Systems Large diopter range real time sequential wavefront sensor
US20130194548A1 (en) * 2011-04-07 2013-08-01 Raytheon Company Portable retinal imaging device
US20140361957A1 (en) 2012-01-24 2014-12-11 The Arizonia Board Of Regents On Behalf Of The University Of Arizonz Compact eye-tracked head-mounted display
US20160256324A1 (en) * 2015-03-05 2016-09-08 Kabushiki Kaisha Topcon Laser treatment apparatus
US20160287441A1 (en) * 2006-11-10 2016-10-06 Topcon Medical Laser Systems, Inc. System and method for determining dosimetry in ophthalmic photomedicine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4531950B2 (en) * 2000-08-25 2010-08-25 株式会社トプコン Ophthalmic measuring device
JP6394338B2 (en) * 2014-12-04 2018-09-26 ソニー株式会社 Image processing apparatus, image processing method, and imaging system

Patent Citations (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1015314B (en) 1955-08-16 1957-09-05 August Schwarz Fa Locking arrangement for pneumatic copiers
US4196980A (en) 1974-06-20 1980-04-08 Propper Manufacturing Co., Inc. Opthalmoscope examination pattern having light transmissive fixation point
WO1986000512A1 (en) 1984-07-14 1986-01-30 G. Rodenstock Instrumente Gmbh Eye testing apparatus for examining the bottom of the eye
EP0188470A1 (en) 1984-07-14 1986-07-30 Rodenstock Instr Eye testing apparatus for examining the bottom of the eye.
JPS61502800A (en) 1984-07-14 1986-12-04 ゲ− ロ−デンストツク インストルメント ゲゼルシヤフト ミツト ベシユレンクテル ハフツング Ophthalmological instruments for viewing the fundus of the eye
EP0221649A2 (en) 1985-09-09 1987-05-13 Ocular Instruments, Inc. Slit lamp attachment
JPS62109542A (en) 1985-09-09 1987-05-20 オキユラ− インストルメンツ,インコ−ポレイテツド Attachment for slit lamp
US4801198A (en) 1985-09-09 1989-01-31 Ocular Instruments, Inc. Slit lamp attachment
WO1987005204A1 (en) 1986-03-08 1987-09-11 G. Rodenstock Instrumente Gmbh Slit lamp for the laser treatment of the eye
JPH01500009A (en) 1986-03-08 1989-01-12 ゲー.ローデンストツク.インストルメンテ.ゲゼルシヤフト.ミツト.ベシユレンクテル.ハフツング Split light device for eye treatment using laser
US4917486A (en) 1987-05-20 1990-04-17 Scientific Generics Ltd. Photocoagulation apparatus
JPS6450009A (en) 1987-08-21 1989-02-27 Minolta Camera Kk Light beam scanner
US4995716A (en) 1989-03-09 1991-02-26 Par Technology Corporation Method and apparatus for obtaining the topography of an object
US5299310A (en) 1992-01-15 1994-03-29 Ricoh Company, Ltd. Flexible frame buffer for raster output devices
JPH08117193A (en) 1994-10-20 1996-05-14 Topcon Corp Fundus camera
US5912720A (en) 1997-02-13 1999-06-15 The Trustees Of The University Of Pennsylvania Technique for creating an ophthalmic augmented reality environment
US5943118A (en) 1998-03-19 1999-08-24 Carl Zeiss Jena Gmbh Arrangement and method for illumination in a stereoscopic ophthalmic microscope
WO2000027273A1 (en) 1998-11-06 2000-05-18 Q-Vis Limited Eye tracker for refractive surgery
JP2000262476A (en) 1999-03-15 2000-09-26 Carl Zeiss Jena Gmbh Lighting system in optometric three-dimensional microscope and method therefor
US6394601B1 (en) 2000-07-17 2002-05-28 David S. Bettinger Spectacle-mounted micro display ocular
US20030071970A1 (en) 2001-10-17 2003-04-17 Carl Zeiss Meditec Ag Ophthalmologic examination instrument
US20050107708A1 (en) 2002-01-10 2005-05-19 Walter Wrobel Arrangement and method for illuminating the lens of the human eye
EP1400829A1 (en) 2002-09-17 2004-03-24 Leica Microsystems (Schweiz) AG Microscope for ophthalmologic surgery with object illumination
US20040061932A1 (en) 2002-09-17 2004-04-01 Juergen Pensel Ophthalmic surgical microscope with a subject illumination system
US7766481B2 (en) 2004-04-24 2010-08-03 Carl Zeiss Meditec Gmbh Device for illuminating organic objects
US20050277913A1 (en) 2004-06-09 2005-12-15 Mccary Brian D Heads-up display for displaying surgical parameters in a surgical microscope
US20050288564A1 (en) * 2004-06-18 2005-12-29 Iuliano Michael J Method and apparatus for performing in-vivo blood analysis using raman spectrum
US20090153796A1 (en) 2005-09-02 2009-06-18 Arthur Rabner Multi-functional optometric-ophthalmic system for testing diagnosing, or treating, vision or eyes of a subject, and methodologies thereof
US20070126985A1 (en) * 2005-10-28 2007-06-07 Wiltberger Michael W Photomedical treatment system and method with a virtual aiming device
US20130128228A1 (en) 2006-01-20 2013-05-23 Clarity Medical Systems Large diopter range real time sequential wavefront sensor
EP2012696A2 (en) 2006-04-28 2009-01-14 Optimedica Corporation Dynamic optical surgical system utilizing a fixed relationship between target tissue visualization and beam delivery
US20120165906A1 (en) 2006-07-07 2012-06-28 Od-Os Gmbh Ophthalmoscope including virtual position patterning for therapy beam application
US20120165905A1 (en) 2006-07-07 2012-06-28 Od-Os Gmbh Ophthalmoscope including therapy beam targeting
US20080015553A1 (en) * 2006-07-12 2008-01-17 Jaime Zacharias Steering laser treatment system and method of use
US20080018987A1 (en) 2006-07-20 2008-01-24 Microvision, Inc. Compact multicolor light beam source
US20160287441A1 (en) * 2006-11-10 2016-10-06 Topcon Medical Laser Systems, Inc. System and method for determining dosimetry in ophthalmic photomedicine
US20100271594A1 (en) 2007-04-13 2010-10-28 Carl Zeiss Meditec Ag Device and Method for Axial Length Measurement Having Expanded Measuring Function in the Anterior Eye Segment
US20090093798A1 (en) 2007-10-05 2009-04-09 Steven Thomas Charles Semi-automated ophthalmic photocoagulation method and apparatus
US20100202036A1 (en) 2007-11-29 2010-08-12 Oasis Advanced Engineering, Inc. Multi-purpose periscope with display and overlay capabilities
WO2009145738A1 (en) 2008-05-30 2009-12-03 Optotek D.O.O. Slit lamp with an optoelectronic slit
US20110052042A1 (en) 2009-08-26 2011-03-03 Ben Tzvi Jacob Projecting location based elements over a heads up display
WO2012060724A1 (en) 2010-11-05 2012-05-10 Anthony Philip Wells Eye examination system
US20130301003A1 (en) 2010-11-05 2013-11-14 Anthony Philip Wells Eye examination system
US20130194548A1 (en) * 2011-04-07 2013-08-01 Raytheon Company Portable retinal imaging device
CN102768403A (en) 2011-05-03 2012-11-07 上海美沃精密仪器有限公司 Micro-display slit system and micro-display slit method
CN202044247U (en) 2011-05-03 2011-11-23 上海美沃精密仪器有限公司 Micro-display slit device
US20140361957A1 (en) 2012-01-24 2014-12-11 The Arizonia Board Of Regents On Behalf Of The University Of Arizonz Compact eye-tracked head-mounted display
US20160256324A1 (en) * 2015-03-05 2016-09-08 Kabushiki Kaisha Topcon Laser treatment apparatus

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
European Communication Pursuant to 94(3) EPC dated Feb. 18, 2021, In connection with European Patent Application No. 14847231.9, 6 pgs.
Extended European Search Report dated May 15, 2017 in connection with European Patent Application No. 14 847 231.9-1666, 8 pages.
International Search Report and Written Opinion dated Apr. 4, 2019, in connection with International Patent Application No. PCT/US2019/013421, 11 pgs.
International Search Report and Written Opinion dated Dec. 24, 2014, in connection with related international patent application No. PCT/US14/57360, 8 pgs.
International Search Report and Written Opinion dated Feb. 20, 2015, in connection with International Patent Application No. PCT/US14/68301, 15 pgs.
Notification of Reasons for Refusal dated Aug. 14, 2018 in connection with Japanese Application No. 2016-538042.
Palanker et al., "The Impact of Pulse Duration and Burn Grade on Size of Retinal Photocoagulation Lesion: Implications for Pattern Density," Retina, The Journal of Retinal and Vitreous Diseases, vol. 31, No. 8, pp. 1664-1669.

Also Published As

Publication number Publication date
US20220062036A1 (en) 2022-03-03
US20190224043A1 (en) 2019-07-25
JP2021511095A (en) 2021-05-06
EP3740803A1 (en) 2020-11-25
WO2019143544A1 (en) 2019-07-25

Similar Documents

Publication Publication Date Title
US11406263B2 (en) Photomedical treatment system and method with a virtual aiming device
JP5842330B2 (en) Fundus photocoagulation laser device
US9788719B2 (en) Fundus imaging apparatus and method
JP7164339B2 (en) Photocoagulator
US20150157198A1 (en) Ophthalmic Illumination System with Micro-Display Overlaid Image Source
JP6619202B2 (en) Ophthalmic imaging equipment
CN107529981A (en) Tracking system for surgical operation optical coherence tomography
WO2016084419A1 (en) Ophthalmological imaging device
KR101268413B1 (en) Optical coherent tomography monitoring microscope
US11871991B2 (en) Image processing method, program, and image processing device
JP6942536B2 (en) Laser treatment device
US20220062036A1 (en) System and method for a patient-invisible laser treatment alignment pattern in ophthalmic photomedicine
JP2012223428A (en) Ophthalmic apparatus
US11534338B2 (en) System for laser photocoagulation of the retina
JP2019058493A (en) Laser treatment device, ophthalmologic information processing device, and ophthalmologic system
JP7164338B2 (en) Photocoagulator, fundus observation device, program, and recording medium
JP2015016377A (en) Fundus observation apparatus
JP2019171220A (en) Ophthalmological photographing apparatus
JP2021049278A (en) Ophthalmologic apparatus, ophthalmologic apparatus control method, and program
JP2019118419A (en) Ophthalmologic imaging apparatus, control method therefor, program, and recording medium
JP2018019906A (en) Ophthalmological photographing device, ophthalmological photographing method, and program
JP2016093510A (en) Ocular fundus laser photocoagulator

Legal Events

Date Code Title Description
AS Assignment

Owner name: TOPCON MEDICAL LASER SYSTEMS INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SRAMEK, CHRIS;REEL/FRAME:044663/0173

Effective date: 20180112

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

AS Assignment

Owner name: IRIDEX CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:TOPCON MEDICAL LASER SYSTEMS, INC.;REEL/FRAME:056490/0143

Effective date: 20210310

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY